The Role of Transglutaminases in the Pathophysiology of Prostate Cancer
1
Department of Pathology, University of Arizona College of Medicine, PO Box 245043, Tucson, AZ 85724-5043, USA
2
Department of Pathology, University of Arizona College of Medicine, Arizona Cancer Center and BIO5 Institute, Tucson, AZ 85719, USA
3
Metastasis and Angiogenesis Research Group, Department of Surgery, Cardiff University School of Medicine, Cardiff CF14 4YS, UK
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(5), 241-242; https://doi.org/10.3747/co.v18i5.853
Submission received: 3 August 2011
/
Accepted: 6 September 2011
/
Published: 1 October 2011
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Quantification of the enzymatic activity of macromolecules has been a longstanding adjunctive approach in the diagnosis and prognosis of a variety of diseases, including cancer.[...]
Share and Cite
MDPI and ACS Style
Ablin, R.J.; Jiang, W.G. The Role of Transglutaminases in the Pathophysiology of Prostate Cancer. Curr. Oncol. 2011, 18, 241-242. https://doi.org/10.3747/co.v18i5.853
AMA Style
Ablin RJ, Jiang WG. The Role of Transglutaminases in the Pathophysiology of Prostate Cancer. Current Oncology. 2011; 18(5):241-242. https://doi.org/10.3747/co.v18i5.853
Chicago/Turabian StyleAblin, Richard J., and Wen G. Jiang. 2011. "The Role of Transglutaminases in the Pathophysiology of Prostate Cancer" Current Oncology 18, no. 5: 241-242. https://doi.org/10.3747/co.v18i5.853
